Bonnie Glisson
Medical Oncology · Houston, TXNPI 1073611950
Payments from drug & device makers
Across 27 payments — averaging $20,754 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$418K
- Merck$101K
- AstraZeneca$30K
- Regeneron Healthcare Solutions, Inc.$7K
- AbbVie$5K
What the payments were for
- Consulting fees$7,205100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 18 | $417,950 |
| Merck | 1 | $100,674 |
| AstraZeneca | 1 | $30,027 |
| Regeneron Healthcare Solutions, Inc. | 5 | $7,205 |
| AbbVie | 2 | $4,500 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIBTAYO$7,205
How this compares
$560,356 in reported general payments places this provider in the 65th percentile of 495 medical oncology providers in Texas.
Other medical oncology in Houston
- Hagop KantarjianHouston$100.5M
- Timothy YapHouston$56.7M
- Yasir ElaminHouston$41.3M
- David HongHouston$31.6M
- Guillermo Garcia-ManeroHouston$31.6M
- Jason WestinHouston$30.8M
- Lucia MasarovaHouston$29.7M
- Jordi Rodon AhnertHouston$28.1M
- Sarina Piha PaulHouston$26M
- Jenny ChangHouston$17.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.